1. Home
  2. WH vs ASND Comparison

WH vs ASND Comparison

Compare WH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WH
  • ASND
  • Stock Information
  • Founded
  • WH 2017
  • ASND 2006
  • Country
  • WH United States
  • ASND Denmark
  • Employees
  • WH N/A
  • ASND N/A
  • Industry
  • WH Hotels/Resorts
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • WH Consumer Discretionary
  • ASND Health Care
  • Exchange
  • WH Nasdaq
  • ASND Nasdaq
  • Market Cap
  • WH 7.9B
  • ASND 8.4B
  • IPO Year
  • WH N/A
  • ASND 2015
  • Fundamental
  • Price
  • WH $103.30
  • ASND $128.13
  • Analyst Decision
  • WH Strong Buy
  • ASND Strong Buy
  • Analyst Count
  • WH 9
  • ASND 14
  • Target Price
  • WH $107.56
  • ASND $192.07
  • AVG Volume (30 Days)
  • WH 679.3K
  • ASND 374.2K
  • Earning Date
  • WH 02-12-2025
  • ASND 02-05-2025
  • Dividend Yield
  • WH 1.47%
  • ASND N/A
  • EPS Growth
  • WH N/A
  • ASND N/A
  • EPS
  • WH 3.14
  • ASND N/A
  • Revenue
  • WH $1,383,000,000.00
  • ASND $365,187,374.00
  • Revenue This Year
  • WH $5.27
  • ASND $9.76
  • Revenue Next Year
  • WH $5.97
  • ASND $81.02
  • P/E Ratio
  • WH $32.88
  • ASND N/A
  • Revenue Growth
  • WH 0.73
  • ASND 115.54
  • 52 Week Low
  • WH $67.67
  • ASND $111.09
  • 52 Week High
  • WH $105.16
  • ASND $161.00
  • Technical
  • Relative Strength Index (RSI)
  • WH 62.52
  • ASND 41.36
  • Support Level
  • WH $98.50
  • ASND $126.38
  • Resistance Level
  • WH $103.71
  • ASND $137.54
  • Average True Range (ATR)
  • WH 1.89
  • ASND 5.53
  • MACD
  • WH 0.01
  • ASND -1.14
  • Stochastic Oscillator
  • WH 88.40
  • ASND 11.21

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2023, Wyndham Hotels & Resorts operates 872,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 19% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 57% of total rooms.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Share on Social Networks: